Jeffrey S Greiwe

Title: The Innovations of Jeffrey S. Greiwe

Introduction

Jeffrey S. Greiwe is a notable inventor based in Ft. Thomas, KY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of tranexamic acid formulations. With a total of 9 patents to his name, Greiwe's work focuses on enhancing patient compliance and minimizing adverse effects associated with medication.

Latest Patents

Greiwe's latest patents include innovative formulations of tranexamic acid. One patent discloses modified release oral tranexamic acid formulations and methods of treatment. Another patent focuses on tranexamic acid formulations with reduced adverse effects, specifically designed to minimize nausea, vomiting, and other gastric issues that may arise during therapy. These formulations include an extended release version that utilizes waxes and polymers to prevent a bolus release of tranexamic acid in the stomach. Additionally, a delayed release formulation is designed to release the medication in the less acidic environment of the intestines, thereby enhancing patient compliance.

Career Highlights

Throughout his career, Jeffrey S. Greiwe has been associated with Ferring B.V., where he has contributed to the advancement of pharmaceutical innovations. His work has been instrumental in developing formulations that improve the therapeutic experience for patients.

Collaborations

Greiwe has collaborated with notable colleagues, including Keith A. Moore and Ralph A. Heasley, to further enhance the impact of his inventions in the pharmaceutical industry.

Conclusion

Jeffrey S. Greiwe's contributions to the field of pharmaceuticals through his innovative tranexamic acid formulations demonstrate his commitment to improving patient care. His work continues to influence the development of effective treatments that prioritize patient comfort and compliance.